Key result
Advanced in vivo imaging enables non-invasive tracking of monocyte and macrophage dynamics in atherosclerosis.
Why the study?
The complex systemic interactions between bone marrow, monocytes/macrophages, and atherosclerotic plaques, including extra-medullary hematopoietic sites, are only beginning to be understood.
Answers are grounded in this paper and cite their sources.
Integrating systemic biology with multi-modality imaging offers a comprehensive organ-systems approach to assessing atherosclerosis risk and progression.
It has long been recognized that the bone marrow is the primary site of origin for circulating monocytes that may later become macrophages in atherosclerotic lesions. However, only in recent times has the complex relationship between the bone marrow, monocytes/macrophages and atherosclerotic plaques begun to be understood. Moreover, the systemic nature of these interactions, which also involves additional compartments such as extra-medullary hematopoietic sites (i.e., spleen), are only just becoming apparent. In parallel, progressive advances in imaging and cell labeling techniques have opened new opportunities for in vivo imaging of monocyte/macrophage trafficking in atherosclerotic lesions and at the systemic level. In this part 3 of a 4-part review series covering the macrophage in cardiovascular disease we intersect systemic biology with advanced imaging techniques to explore monocyte and macrophage dynamics in the cardiovascular system, with an emphasis on how events at the systemic level might impact local atherosclerotic plaque biology.
No takes yet. Share an insight, caveat, or question.
Fayad et al. (2018) conducted a review in Atherosclerosis and Cardiovascular Disease. Advanced in vivo imaging techniques provide new opportunities to non-invasively assess monocyte and macrophage dynamics both systemically and locally within atherosclerotic lesions.
Synapse has enriched 10 related papers. Consider them for comparative context: